These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 23199790)

  • 1. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
    Thanassoulis G
    Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization: use of genetics to enable causal inference in observational studies.
    Verduijn M; Siegerink B; Jager KJ; Zoccali C; Dekker FW
    Nephrol Dial Transplant; 2010 May; 25(5):1394-8. PubMed ID: 20190244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method].
    Nilsson PM
    Lakartidningen; 2013 Apr 17-23; 110(16):832-5. PubMed ID: 23717930
    [No Abstract]   [Full Text] [Related]  

  • 4. Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.
    He W; Castiblanco J; Walter EA; Okulicz JF; Ahuja SK
    Curr Opin HIV AIDS; 2010 Nov; 5(6):545-59. PubMed ID: 20978399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power and sample size calculations for Mendelian randomization studies using one genetic instrument.
    Freeman G; Cowling BJ; Schooling CM
    Int J Epidemiol; 2013 Aug; 42(4):1157-63. PubMed ID: 23934314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps.
    Ference BA
    Curr Opin Lipidol; 2015 Dec; 26(6):566-71. PubMed ID: 26780009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian randomisation applied to drug development in cardiovascular disease: a review.
    Mokry LE; Ahmad O; Forgetta V; Thanassoulis G; Richards JB
    J Med Genet; 2015 Feb; 52(2):71-9. PubMed ID: 25515070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease.
    Jansen H; Lieb W; Schunkert H
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):41-9. PubMed ID: 26791863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention.
    Orho-Melander M
    J Intern Med; 2015 Nov; 278(5):433-46. PubMed ID: 26477595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization analysis of case-control data using structural mean models.
    Bowden J; Vansteelandt S
    Stat Med; 2011 Mar; 30(6):678-94. PubMed ID: 21337362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian Randomization versus Path Models: Making Causal Inferences in Genetic Epidemiology.
    Ziegler A; Mwambi H; König IR
    Hum Hered; 2015; 79(3-4):194-204. PubMed ID: 26201704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to Mendelian randomization with applications in neurology.
    Allman PH; Aban IB; Tiwari HK; Cutter GR
    Mult Scler Relat Disord; 2018 Aug; 24():72-78. PubMed ID: 29960142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mendelian randomisation: a tool for assessing causality in observational epidemiology.
    Sheehan NA; Meng S; Didelez V
    Methods Mol Biol; 2011; 713():153-66. PubMed ID: 21153618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mendelian randomisation in cardiovascular research: an introduction for clinicians.
    Bennett DA; Holmes MV
    Heart; 2017 Sep; 103(18):1400-1407. PubMed ID: 28596306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Mendelian randomization to determine causative factors in cardiovascular disease.
    Johansen CT; Hegele RA
    J Intern Med; 2013 Jan; 273(1):44-7. PubMed ID: 22928522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genotype-disease association and possibility to reveal environmentally modifiable disease causes: the use of mendelian randomization principle].
    Novotný L; Bencko V
    Cas Lek Cesk; 2007; 146(4):343-50. PubMed ID: 17491244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization and estimation of treatment efficacy for chronic diseases.
    Schooling CM; Freeman G; Cowling BJ
    Am J Epidemiol; 2013 May; 177(10):1128-33. PubMed ID: 23585329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection.
    Rosenson RS; Koenig W
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):65-74. PubMed ID: 26797681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian randomization: present and future of epidemiological studies in cardiology.
    Iturrieta-Zuazo I; Walter S
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):87-91. PubMed ID: 25449812
    [No Abstract]   [Full Text] [Related]  

  • 20. Insight into rheumatological cause and effect through the use of Mendelian randomization.
    Robinson PC; Choi HK; Do R; Merriman TR
    Nat Rev Rheumatol; 2016 Aug; 12(8):486-96. PubMed ID: 27411906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.